FDA Releases FY 2018 Numbers for Fast-Tracked ANDA Generics

Drug Industry Daily
A A
The FDA logged a steadily increasing number of fast-tracked ANDAs in fiscal year 2018, according to the agency’s first annual report mandated by the FDA Reauthorization Act.

To View This Article:

Login

Subscribe To Drug Industry Daily